カテゴリ： MarketLine, 企業調査, 日本

Taisho Pharmaceutical Holdings Co Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4459
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：35
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) develops, manufactures and markets self-medication drugs and prescription pharmaceuticals. Its self-medication products comprise over-the-counter (OTC) products, quasi-drugs and health food products. The company’s prescription pharmaceuticals portfolio includes ethical drugs in the fields of infectious diseases, orthopedic disorders, central nervous system (CNS) diseases and metabolic diseases. Taisho Pharmaceutical also has various products in pipeline such as TS-091 for central disorders of hypersomnolence; TS-141 for childhood attention-deficit/hyperactivity disorder; TS-121 for depression; and TS-133 for alopecia, among others. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Singapore, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Toshima-ku, Tokyo, Japan.

Scope

- Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
- Intelligence on Taisho Pharmaceutical Holdings Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Taisho Pharmaceutical Holdings Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Taisho Pharmaceutical Holdings Co Ltd: Company Overview 9
Taisho Pharmaceutical Holdings Co Ltd: Overview and Key Facts 9
Taisho Pharmaceutical Holdings Co Ltd: Overview 9
Taisho Pharmaceutical Holdings Co Ltd: Key Facts 9
Taisho Pharmaceutical Holdings Co Ltd: Key Employees 10
Taisho Pharmaceutical Holdings Co Ltd: Key Employee Biographies 11
Taisho Pharmaceutical Holdings Co Ltd: Major Products and Services 12
Taisho Pharmaceutical Holdings Co Ltd: Company History 13
Taisho Pharmaceutical Holdings Co Ltd: Management Statement 15
Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries 16
Taisho Pharmaceutical Holdings Co Ltd: Key Competitors 18
Taisho Pharmaceutical Holdings Co Ltd: Company Analysis 19
Taisho Pharmaceutical Holdings Co Ltd: Business Description 19
Taisho Pharmaceutical Holdings Co Ltd: SWOT Analysis 20
Taisho Pharmaceutical Holdings Co Ltd: SWOT Overview 20
Taisho Pharmaceutical Holdings Co Ltd: Strengths 20
Taisho Pharmaceutical Holdings Co Ltd: Weaknesses 21
Taisho Pharmaceutical Holdings Co Ltd: Opportunities 21
Taisho Pharmaceutical Holdings Co Ltd: Threats 22
Taisho Pharmaceutical Holdings Co Ltd: Corporate Financial Deals Activity 23
Taisho Pharmaceutical Holdings Co Ltd: Financial Deals Overview 23
Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners 25
Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2014 – 2018YTD* 26
Taisho Pharmaceutical Holdings Co Ltd: Mergers and Acquisitions 27
Taisho Pharmaceutical Holdings Co Ltd: Partnership 28
Taisho Pharmaceutical Holdings Co Ltd: Divestments 29
Taisho Pharmaceutical Holdings Co Ltd: Recent Developments 30
Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary 30
Taisho Pharmaceutical Holdings Co Ltd: Financial Performance 30
Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events 31
Taisho Pharmaceutical Holdings Co Ltd: Strategy and Operations 32
Appendix 33
Contact Us 33
Methodology 33
About MarketLine 34

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Table 2: Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Table 3: Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Table 4: Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Table 5: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (TTM*)
Table 7: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Table 9: Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Table 10: Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2014 - 2018YTD*
Table 11: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Taisho Pharmaceutical Holdings Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Taisho Pharmaceutical Holdings Co Ltd: Divestments by Geography (2014 - YTD*2018)
Table 17: Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Table 18: Taisho Pharmaceutical Holdings Co Ltd: Financial Performance
Table 19: Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events
Table 20: Taisho Pharmaceutical Holdings Co Ltd: Strategy and Operations

List of Figures
Figure 1: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (TTM*)
Figure 3: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Taisho Pharmaceutical Holdings Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Taisho Pharmaceutical Holdings Co Ltd: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • GeNeuro SA (GNRO)：企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Sfinks Polska S.A.：企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Saudi Arabian Fertilizers Co (2020)：企業の財務・戦略的SWOT分析
    Saudi Arabian Fertilizers Co (2020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Gunma Bank Ltd：企業の戦略・SWOT・財務分析
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SOLX Inc-医療機器分野：企業M&A・提携分析
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • HTG Molecular Diagnostics Inc (HTGM)：企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Auspex Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Auspex Pharmaceuticals Inc (Auspex), a subsidiary of Teva Pharmaceutical Industries Ltd is a biopharmaceutical company that develops and commercializes novel medicines for the treatment of movement disorders and other rare diseases including orphan diseases. The company offers products for t …
  • Valneva SE (VLA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • Core-Mark Holding Company, Inc. (CORE)：企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Steelcase Inc (SCS)：企業の財務・戦略的SWOT分析
    Steelcase Inc (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Galp Energia SGPS SA (GALP)：電力：M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • American Gene Technologies International Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomi …
  • Jacobs Engineering Group Inc (JEC)：電力：M&Aディール及び事業提携情報
    Summary Jacobs Engineering Group Inc (Jacobs) is a professional services company. It offers a diverse range of technical, professional, and construction services. The company's service portfolio includes project; process, scientific and specialty consulting; engineering and construction; and operati …
  • Conversant Intellectual Property Management Inc.：企業のM&A・事業提携・投資動向
    Conversant Intellectual Property Management Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Conversant Intellectual Property Management Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • nib Holdings Limited：企業の戦略・SWOT・財務情報
    nib Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vertex Pharmaceuticals Inc (VRTX)：企業の財務・戦略的SWOT分析
    Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Avara Pharmaceutical Services Inc-製薬・医療分野：企業M&A・提携分析
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • BBA Aviation plc：企業の戦略・SWOT・財務情報
    BBA Aviation plc - Strategy, SWOT and Corporate Finance Report Summary BBA Aviation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • VWR International LLC-製薬・医療分野：企業M&A・提携分析
    Summary VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, b …
  • Sagemcom SAS：企業の戦略的SWOT分析
    Sagemcom SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆